Table 3 Demographic and baseline characteristics of the two patient groups after PSM (N = 322).
From: D-dimer, a predictor of bad outcome in gastric cancer patients undergoing radical resection
Characteristics | Total | NDG | EDG | P value |
---|---|---|---|---|
(N = 322) | (N = 161) | (N = 161) | ||
Gender, no. (%) | 0.211 | |||
Female | 88(27.3) | 39(24.2) | 49(30.4) | |
Male | 234(72.7) | 122(75.8) | 112(69.6) | |
Tumor location, no. (%) | 0.011 | |||
proximal stomach | 131(40.7) | 78(48.4) | 53(32.9) | |
distal stomach | 145(45) | 60(37.3) | 85(52.8) | |
most or total stomach | 46(14.3) | 23(14.3) | 23(14.3) | |
Age ≥ 65 years. No. (%) | 157(48.8) | 78(48.4) | 79(49.1) | 0.911 |
PT, second | 13(12.4–13.53) | 12.9(12.35–13.4) | 13.1(12.6–13.7) | 0.02 |
PTA, % | 94.1(82.9–105.45) | 94.45(86.2–108.5) | 94.9(78.9–104.7) | 0.142 |
PTR | 1.03(0.99–1.08) | 1.03(0.99–1.07) | 1.02(0.99–1.08) | 0.942 |
APTT, second | 34.6(31.7–37) | 1.02(0.98–1.07) | 1.03(1–1.09) | 0.669 |
INR | 1.03(0.99–1.08) | 34.5(32–37.2) | 34.7(31.55–36.95) | 0.086 |
TT, second | 16.2(15.7–16.8) | 16.2(15.75–16.75) | 16.2(15.6–16.85) | 0.953 |
FIB, g/l | 3.35(2.71–4) | 3.18(2.7–3.8) | 3.44(2.81–4.2) | 0.04 |
D-dimer, mg/l | 1.01(0.3–1.71) | 0.3(0.1–0.6) | 1.7(1.2–2.75) | < 0.001 |
FDP, mg/l | 1.62(0.9–3.2) | 1(0.6–1.3) | 3.2(2.3–5.4) | < 0.001 |
Platelet | 199(153–252) | 198(151–255.5) | 200(155.8–250.5) | 0.8 |
T stage, no. (%) | 0.737 | |||
T1 | 33(10.2) | 15(9.3) | 18(11.2) | |
T2 | 20(6.2) | 12(7.5) | 8(5) | |
T3 | 81(25.2) | 42(26.1) | 39(24.2) | |
T4 | 188(58.4) | 92(57.1) | 96(59.6) | |
N stage, no. (%) | 0.01 | |||
N0 | 91(28.3) | 40(24.8) | 51(31.7) | |
N1 | 50(15.5) | 29(18) | 21(13) | |
N2 | 77(23.9) | 49(30.4) | 28(17.4) | |
N3 | 104(32.3) | 43(26.7) | 61(37.9) | |
TNM stage, no. (%) | 0.057 | |||
I | 41(12.7) | 17(10.6) | 24(14.9) | |
II | 53(16.5) | 34(21.1) | 19(11.8) | |
III | 228(70.8) | 110(68.3) | 118(73.3) | |
Chemotherapy | 0.204 | |||
yes | 238(73.9) | 114(70.8) | 124(77) | |
no | 84(26.1) | 47(29.2) | 37(23) | |
Histology, no. (%) | 0.051 | |||
differentiated | 123(38.2) | 70(43.5) | 53(32.9) | |
undifferentiated | 199(61.8) | 91(56.5) | 108(67.1) | |
OS, month | 24(13–44) | 25(15–47.5) | 19(10–42.4) | 0.005 |
DFS, month | 23(12–44) | 24(14–48) | 18.5(9–43.25) | 0.007 |
LNR | 0.21(0–0.44) | 0.21(0–0.36) | 0.21(0–0.57) | 0.921 |
Tumor size, cm | 4(3–5.5) | 3(2.5–4) | 4.5(3–6) | < 0.001 |